Tasso is a Medical innovation company changing the way diagnostics are delivered
Tasso is revolutionizing blood-based diagnostics by placing the user at the center of the diagnostics process. Patients are able to sample their own blood in the comfort of their home with a device that is safe, simple, and convenient.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 16, 2021 | Series B | $100M | 1 | — | — | Detail |
Jul 22, 2020 | Series A | $17M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Hambrecht Ducera Growth Ventures | — | Series B |
Hambrecht Healthcare Growth Venture Fund | — | Series A |